JONATHAN RHODES: Open Payments
NPI 1477062800 · ABERDEEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 31 payments from 6 companies in 2025. Trend: 2023 $575 · 2024 $132 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $266 |
| Novartis Pharmaceuticals Corporation | 1 | $106 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, LEQVIO, COBENFY, CAPLYTA, REXULTI, FANAPT.
Industry payments across NJ — which companies pay providers there.
